About BioAuxilium
BioAuxilium specialises in the design, development and manufacture of ready-to-use TR-FRET assay kits for drug discovery and life science research. Its expertise focuses on homogeneous assays for the quantification of endogenous proteins in cells, enabling researchers to generate reliable quantitative data while streamlining laboratory workflows. The company’s proprietary THUNDER™ platform combines validated antibodies, high-performance TR-FRET fluorophores and controlled manufacturing processes to deliver reproducible assay performance across a range of biological applications. These assays support research in cell biology, target validation, pharmacology and early-stage drug discovery.
The THUNDER™ portfolio includes fully validated TR-FRET assay kits supplied with comprehensive technical documentation and assay validation data. Alongside its catalogue products, BioAuxilium provides custom TR-FRET assay development and optimisation services for research and drug discovery programmes. All assays are developed, validated and manufactured in-house to support consistent product quality and lot-to-lot reproducibility. The company also works with academic laboratories, research institutes and biotechnology organisations on antibody evaluation, fluorophore testing and the development of new assay formats.
Europa Biosite’s subsidiaries distribute for BioAuxilium in Austria and Switzerland.